India’s Drug Regulatory body probes contaminated eye drops after US FDA flagged 55 adverse events cases2 min read . Updated: 04 Feb 2023, 05:38 AM IST
- Using contaminated artificial tears increases risk of eye infections that could result in blindness or death, US FDA said
Hours after Indian pharmaceutical company--Global Pharma Healthcare issued voluntary nationwide recall of its “artificial tears" --lubricant eye drops due to “possible contamination"; the union health ministry’s Central Drugs Standard Control Organization (CDSCO) and State Drug Controller have sent their team to plant located about 40 km south of Chennai, person aware of the matter said.
Select your Category